JPMORGAN CHASE & CO

Position in FTRE — Fortrea Holdings Inc.

CIK 19617 NEW YORK, NY

Position in FTRE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$10,108,268

+$590,671 QoQ

Shares Held

580,935

-42.5% QoQ

Ownership

0.611%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. FTRE ranks #85 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,108,268	580,935	-42.5%	Shares	Other	2026-08-12
2026-03-31	$9,517,597	1,010,361	+82.2%	Shares	Other	2026-05-13
2025-12-31	$9,566,261	554,566	-19.9%	Shares	Other	2026-02-11
2025-09-30	$5,832,548	692,702	+65.5%	Shares	Other	2025-11-07
2025-06-30	$2,067,352	418,493	+55.9%	Shares	Other	2025-08-12
2025-03-31	$2,026,394	268,397	+14.4%	Shares	Other	2025-05-12
2024-12-31	$4,374,353	234,550	-35.6%	Shares	Other	2025-02-12
2024-09-30	$7,288,260	364,413	+21.2%	Shares	Other	2024-12-26
2024-06-30	$7,017,097	300,647	+17.1%	Shares	Other	2024-12-26
2024-03-31	$10,308,509	256,814	-77.3%	Shares	Other	2024-12-26
2023-12-31	$39,437,834	1,130,024	+3.4%	Shares	Other	2024-02-12
2023-09-30	$31,241,746	1,092,751	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.